Talia H. Swartz Department of Medicine, Division of Infectious Diseases Icahn School of Medicine at Mount Sinai Biography Publications Institution JoVE Articles Talia H. Swartz has not added a biography. If you are Talia H. Swartz and would like to personalize this page please email our Author Liaison for assistance. Publications How the Field of Infectious Diseases Can Leverage Digital Strategy and Social Media Use During a Pandemic Open Forum Infectious Diseases. Feb, 2021 | Pubmed ID: 33634204 Joint ESCMID, FEMS, IDSA, ISID and SSI Position Paper on the Fair Handling of Career Breaks Among Physicians and Scientists when Assessing Eligibility for Early-career Awards Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. Feb, 2021 | Pubmed ID: 33609786 P2RX7 at the Host-Pathogen Interface of Infectious Diseases Microbiology and Molecular Biology Reviews : MMBR. 02, 2021 | Pubmed ID: 33441488 Location Matters: Geographic Disparities and Impact of Coronavirus Disease 2019 The Journal of Infectious Diseases. Nov, 2020 | Pubmed ID: 32942299 A Diverse Physician-Scientist Pipeline to Fight Structural Racism Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. Sep, 2020 | Pubmed ID: 32926165 How to Make Your Research Jump off the Page: Co-creation to Broaden Public Engagement in Medical Research PLoS Medicine. 09, 2020 | Pubmed ID: 32925970 An Inflammatory Cytokine Signature Predicts COVID-19 Severity and Survival Nature Medicine. 10, 2020 | Pubmed ID: 32839624 Targeting the NLRP3 Inflammasome in Severe COVID-19 Frontiers in Immunology. 2020 | Pubmed ID: 32655582 Racial Disparity of Coronavirus Disease 2019 in African American Communities The Journal of Infectious Diseases. 08, 2020 | Pubmed ID: 32599614 NLRP3 Inflammasome Signaling As a Link Between HIV-1 Infection and Atherosclerotic Cardiovascular Disease Frontiers in Cardiovascular Medicine. 2020 | Pubmed ID: 32596261 Purinergic Receptors: Elucidating the Role of These Immune Mediators in HIV-1 Fusion Viruses. 03, 2020 | Pubmed ID: 32155980 P2X1 Selective Antagonists Block HIV-1 Infection Through Inhibition of Envelope Conformation-Dependent Fusion Journal of Virology. 02, 2020 | Pubmed ID: 31852781 The Science and Value of Diversity: Closing the Gaps in Our Understanding of Inclusion and Diversity The Journal of Infectious Diseases. 08, 2019 | Pubmed ID: 31430380 Risk of Invasive Anal Cancer in HIV-Infected Patients With High-Grade Anal Dysplasia: A Population-Based Cohort Study Diseases of the Colon and Rectum. 08, 2019 | Pubmed ID: 30888979 P2X Antagonists Inhibit HIV-1 Productive Infection and Inflammatory Cytokines Interleukin-10 (IL-10) and IL-1β in a Human Tonsil Explant Model Journal of Virology. 01, 2019 | Pubmed ID: 30305360 An Electronic Antimicrobial Stewardship Intervention Reduces Inappropriate Parenteral Antibiotic Therapy Infection Control and Hospital Epidemiology. 11, 2018 | Pubmed ID: 30231950 Differences in the Immune Microenvironment of Anal Cancer Precursors by HIV Status and Association With Ablation Outcomes The Journal of Infectious Diseases. 02, 2018 | Pubmed ID: 28968881 A High Throughput Cre-lox Activated Viral Membrane Fusion Assay Identifies Pharmacological Inhibitors of HIV Entry Virology. Mar, 2016 | Pubmed ID: 26803470 Purinergic Receptors: Key Mediators of HIV-1 Infection and Inflammation Frontiers in Immunology. 2015 | Pubmed ID: 26635799 IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein Cell Reports. Oct, 2015 | Pubmed ID: 26387945 P2X-selective Purinergic Antagonists Are Strong Inhibitors of HIV-1 Fusion During Both Cell-to-cell and Cell-free Infection Journal of Virology. Oct, 2014 | Pubmed ID: 25031337 A Clinical Refresher Course for Medical Scientist Trainees Medical Teacher. Jun, 2014 | Pubmed ID: 24527799 多パラメータ光流体プラットフォームを用いたカルシウム流入とHIV-1感染の単細胞特性 Tracey Freeman1, Christina Andreou2, Robert P. Sebra3,4, Kristin G. Beaumont2, Talia H. Swartz1 1Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, 2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, Icahn Institute of Data Science and Genomic Technology, 3Black Family Stem Cell Institute, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, Icahn Institute of Data Science and Genomic Technology, 4Sema4, a Mount Sinai venture JoVE 62632 Imunologia e Infecção
多パラメータ光流体プラットフォームを用いたカルシウム流入とHIV-1感染の単細胞特性 Tracey Freeman1, Christina Andreou2, Robert P. Sebra3,4, Kristin G. Beaumont2, Talia H. Swartz1 1Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, 2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, Icahn Institute of Data Science and Genomic Technology, 3Black Family Stem Cell Institute, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, Icahn Institute of Data Science and Genomic Technology, 4Sema4, a Mount Sinai venture JoVE 62632 Imunologia e Infecção